Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 5
1953 1
1955 2
1956 2
1957 1
1960 4
1961 13
1962 14
1963 20
1964 15
1965 9
1966 17
1967 21
1968 22
1969 12
1970 19
1971 24
1972 18
1973 15
1974 19
1975 17
1976 28
1977 26
1978 55
1979 54
1980 45
1981 58
1982 69
1983 83
1984 81
1985 99
1986 115
1987 104
1988 114
1989 109
1990 111
1991 108
1992 127
1993 137
1994 140
1995 169
1996 176
1997 161
1998 177
1999 218
2000 224
2001 225
2002 240
2003 283
2004 293
2005 271
2006 298
2007 292
2008 338
2009 327
2010 316
2011 386
2012 385
2013 398
2014 419
2015 459
2016 476
2017 527
2018 459
2019 550
2020 662
2021 745
2022 718
2023 645
2024 609
2025 606
2026 350

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,988 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hamamoto y[au] (746 results)?
Response.
Okumura T, Hotta K, Imai K, Ito S, Kishida Y, Takada K, Kawata N, Yoshida M, Yamamoto Y, Ishiwatari H, Sato J, Matsubayashi H, Ono H. Okumura T, et al. Among authors: yamamoto y. Gastrointest Endosc. 2026 Jan;103(1):202-203. doi: 10.1016/j.gie.2025.08.001. Gastrointest Endosc. 2026. PMID: 41412702 No abstract available.
Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Ohara M, Suda G, Kohya R, Yasui Y, Tsuchiya K, Kurosaki M, Tani J, Maekawa S, Enomoto N, Chuma M, Morimoto M, Kaneko S, Nakagawa M, Asahina Y, Komori A, Kugiyama Y, Baba M, Nakamura A, Ito J, Yamada R, Hosoda S, Yamamoto Y, Yoshida S, Sho T, Sasaki T, Yoda T, Meno A, Yasuura N, Fu Q, Yang Z, Maehara O, Ohnishi S, Tokuchi Y, Kitagataya T, Kawagishi N, Nakai M, Ogawa K, Sakamoto N. Ohara M, et al. Among authors: yamamoto y. Hepatol Int. 2025 Dec;19(6):1371-1381. doi: 10.1007/s12072-025-10875-7. Epub 2025 Aug 28. Hepatol Int. 2025. PMID: 40875102
Dapagliflozin Reduces Epicardial Adipose Tissue and Myocardial Fibrosis in Subclinical Heart Failure: The DAPA-EAT Trial.
Taruya A, Ota S, Shiono Y, Yamano T, Taniguchi M, Yamamoto Y, Hayashi Y, Kuki S, Takano Y, Hashizume T, Teraguchi I, Imanishi T, Ino Y, Emori H, Satogami K, Morimoto J, Shimokawa T, Kitabata H, Shimada K, Tanaka A; DAPA-EAT Investigators. Taruya A, et al. Among authors: yamamoto y. Circulation. 2026 Jan 6;153(1):64-67. doi: 10.1161/CIRCULATIONAHA.125.077630. Epub 2025 Nov 9. Circulation. 2026. PMID: 41206791 Free article. No abstract available.
Development of a Synthetic Lethality-Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate Cancer.
Tani M, Hatano K, Ishizuya Y, Oka T, Kanaki T, Inoguchi S, Yoshimura A, Horibe Y, Liu Y, Nesrine S, Okuda Y, Yamamoto A, Uemura T, Yamamichi G, Hayashi T, Yamamoto Y, Kato T, Kawashima A, Yamaguchi T, Obika S, Yusa K, Nonomura N, Nimura K. Tani M, et al. Among authors: yamamoto y. Cancer Sci. 2025 Dec;116(12):3403-3416. doi: 10.1111/cas.70194. Epub 2025 Sep 16. Cancer Sci. 2025. PMID: 40957713 Free PMC article.
Genetic regulation across germline and somatic variation on the Y chromosome contributes to type 2 diabetes.
Sato G, Yamamoto Y, Sonehara K, Saiki R, Ojima T, Kanai M, Liu A, Edahiro R, Shirai Y, Namba S, Namkoong H, Hasaegawa T, Koyanagi YN, Kasugai Y, Yamaji T, Nakano S, Genovese G, Sipilä TP, Ghazal A, Tanaka H, Azekawa S, Uwamino Y, Yamamoto K, Suzuki K, Hata T, Uemura M, Takeda Y, Kanai A, Higashiue S, Kobayashi S, Afuso H, Matsuura K, Mitsumoto Y, Fujita Y; FinnGen; Japan COVID-19 Task Force; Biobank Japan Project; Oda Y, Suzuki Y, Morisaki T, Ishii M, Kitagawa Y, Koike R, Kimura A, Imoto S, Miyano S, Kanai T, Takayama J, Iwasaki M, Sawada N, Fukunaga K, Matsuo K, Kumanogoh A, Doki Y, Eguchi H, Nakagome S, Tamiya G, Ganna A, Palotie A, Daly MJ, Wilson JF, Yamamoto M, Matsuda K, Ogawa S, Yamauchi T, Kadowaki T, Okada Y. Sato G, et al. Among authors: yamamoto y. Nat Med. 2026 Mar;32(3):894-905. doi: 10.1038/s41591-026-04213-z. Epub 2026 Feb 23. Nat Med. 2026. PMID: 41731096 Free PMC article.
Virological characteristics of SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia.
Wacharapluesadee S, Saikruang W, Lytras S, Matsumoto K, Uriu K, Hinay A Jr, Guo Z, Rattanatumhi K, Supataragul A, Ninwattana S, Thippamom N, Srisuk T, Maneeorn P, Noradechanon K, Duengkae P, Sirichan N, Kosugi Y, Fujita S, Yo MS, Matsunaga R, Hu B, Du L, Wang L, Tsuda M, Oda Y, Nasser H, Kimura KT, Akasaka H, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Asakura T, Shihoya W, Hashiguchi T, Ikeda T, Tanaka S, Chu H, Tsumoto K, Nureki O; Genotype to Phenotype Japan (G2P-Japan) Consortium; Genotype to Phenotype Asia (G2P-Asia) Consortium; Plianchaisuk A, Putcharoen O, Sato K. Wacharapluesadee S, et al. Among authors: yamamoto y. Cell. 2026 May 6:S0092-8674(26)00454-X. doi: 10.1016/j.cell.2026.04.019. Online ahead of print. Cell. 2026. PMID: 42097139 Free article.
Long non-coding RNA PWRN4 associated with post-SVR hepatocellular carcinoma: a genome-wide association study.
Suda G, Sugiyama M, Hikita H, Nishio A, Tatsumi T, Takehara T, Murakawa M, Nakagawa M, Asahina Y, Mizokami M, Kakisaka T, Sakamoto Y, Taketomi A, Miyanishi K, Ueno Y, Haga H, Maekawa S, Enomoto N, Kurosaki M, Kohjima M, Nakamuta M, Tanaka Y, Yamamoto Y, Baba M, Hanamatsu H, Furukawa JI, Ohara M, Kitagataya T, Kawagishi N, Nakai M, Sho T, Ogawa K, Sakamoto N. Suda G, et al. Among authors: yamamoto y. Biomark Res. 2025 Sep 24;13(1):113. doi: 10.1186/s40364-025-00832-9. Biomark Res. 2025. PMID: 40993762 Free PMC article.
12,988 results
You have reached the last available page of results. Please see the User Guide for more information.